CL
VRTX icon

CSS LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

CSS LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-550
Closed -$221K – 1128
2024
Q4 		$221K Sell
550
-450
-45% -$209K 0.01% 759
2024
Q3 		$465K Buy
1,000
+300
+43% +$144K 0.02% 520
2024
Q2 		$328K Hold
700
– – 0.02% 580
2024
Q1 		$293K Sell
700
-18,000
-96% -$7.61M 0.02% 576
2023
Q4 		$7.61M Sell
18,700
-300
-2% -$111K 0.44% 42
2023
Q3 		$6.61M Sell
19,000
-300
-2% -$105K 0.43% 46
2023
Q2 		$6.79M Buy
19,300
+1,300
+7% +$438K 0.42% 47
2023
Q1 		$5.67M Buy
18,000
+13,336
+286% +$4M 0.37% 61
2022
Q4 		$1.35M Buy
4,664
+1,017
+28% +$310K 0.08% 213
2022
Q3 		$1.06M Sell
3,647
-136
-4% -$39.1K 0.05% 332
2022
Q2 		$1.07M Buy
3,783
+1,134
+43% +$304K 0.04% 407
2022
Q1 		$691K Buy
2,649
+1,149
+77% +$273K 0.03% 531
2021
Q4 		$329K Sell
1,500
-47,560
-97% -$9.25M 0.01% 790
2021
Q3 		$8.9M Buy
49,060
+16,744
+52% +$3.27M 0.38% 52
2021
Q2 		$6.52M Buy
+32,316
New +$6.76M 0.27% 74
2020
Q2 		– Sell
-600
Closed -$143K – 766
2020
Q1 		$143K Buy
+600
New +$138K 0.01% 465

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CSS LLC's VRTX Position: Q1 2025 in Review

CSS LLC sold out of Vertex Pharmaceuticals (VRTX) in Q1 2025, closing a stake of 550 shares — an estimated $221K sold.

CSS LLC first reported a position in VRTX in Q1 2020 and held it in 16 quarters. The position peaked at $8.9M in Q3 2021. 1,612 funds tracked by Wall St. Rank hold VRTX as of Q1 2025.

  • CSS LLC reported no remaining Vertex Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • CSS LLC sold 550 Vertex Pharmaceuticals shares in Q1 2025, an estimated $221K.
  • CSS LLC first reported a position in Vertex Pharmaceuticals in Q1 2020 and held it in 16 quarters.
  • CSS LLC's Vertex Pharmaceuticals position peaked at $8.9M in Q3 2021.
  • 1,612 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2025.

Based on CSS LLC's 13F filing for Q1 2025, filed 15 May 2025.